1)福井淳史,他 : 【不育症 最前線】化学妊娠と不育症.産婦の実際60 : 1509-1514, 2011
2)The ESHRE Guideline Group on RLP ; Atik RB, et al : Recurrent pregnancy loss. Guideline of the European Society of Human Reproduction and Embryology. Hum Reprod Open 2 : hoy004, 2018
3)Yamada H, et al : Pre-conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am J Reprod Immunol 50 : 351-354, 2003
4)Fukui A, et al : Natural killer cell subpopulations and cytotoxicity for infertile patients undergoing in vitro fertilization. Am J Reprod Immunol 41 : 413-422, 1999
5)Lachapelle MH, et al : Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 156 : 4027-4034, 1996
6)Fukui A, et al : Expression of natural cytotoxicity receptors and cytokine production on endometrial natural killer cells in women with recurrent pregnancy loss or implantation failure, and the expression of natural cytotoxicity receptors on peripheral blood natural killer cells in pregnant women with a history of recurrent pregnancy loss. J Obstet Gynaecol Res 43 : 1678-1686, 2017
7)Kwak-Kim JY, et al : Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 18 : 767-773, 2003
8)Wegmann TG, et al : Bidirectional cytokine interactions in the maternal-fetal relationship : is successful pregnancy a TH2 phenomenon? Immunol Today 14 : 353-356, 1993
9)Fukui A, et al : Intracellular cytokine expression of peripheral blood natural killer cell subsets in women with recurrent spontaneous abortions and implantation failures. Fertil Steril 89 : 157-165, 2008
10)Lee SK, et al : Th17 and regulatory T cells in women with recurrent pregnancy loss. Am J Reprod Immunol 67 : 311-318, 2012
11)Saito S, et al : Role of paternal antigen-specific treg cells in successful implantation. Am J Reprod Immunol 75 : 310-316, 2016
12)Saito S, et al : Distribution of Th1, Th2, and Th0 and the Th1/Th2 cell ratios in human peripheral and endometrial T cells. Am J Reprod Immunol 42 : 240-245, 1999
13)Lee SK, et al : Determination of clinical cellular immune markers in women with recurrent pregnancy loss. Am J Reprod Immunol 70 : 398-411, 2013
14)Ota K, et al : Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity. Hum Reprod 29 : 208-219, 2014
15)Ota K, et al : 1,25-dihydroxy-vitamin D3 regulates NK-cell cytotoxicity, cytokine secretion and degranulation in women with recurrent pregnancy losses. Eur J Immunol 45 : 3188-3199, 2015
16)Sung N, et al : IVIG Task Force Korean Society of Reproductive Immunology : Intravenous immunoglobulin G in women with reproductive failure : The Korean Society for Reproductive Immunology practice guidelines. Clin Exp Reprod Med 44 : 1-7, 2017
17)Fukui A, et al : NK cell abnormality and its treatment in women with reproductive failures such as recurrent pregnancy loss, implantation failures, preeclampsia, and pelvic endometriosis. Reprod Med Biol 14 : 151-157, 2015
18)福井淳史 : 流産の原因と対策 免疫機構から見た流産の病態解明とその対策.日産婦会誌63 : 2167-2184, 2011
19)Nakagawa K, et al : Immunosuppressive treatment using tacrolimus promotes pregnancy outcome in infertile women with repeated implantation failures. Am J Reprod Immunol 78 : e12682, 2017
20)Nakagawa K, et al : Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1/TH2 cell ratios. Am J Reprod Immunol 73 : 353-361, 2015
21)Ahmadi M, et al : Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss(RPL). Biomed Pharmacother 92 : 1095-1102, 2017
22)Ghasemnejad-Berenji H, et al : Immunomodulatory effects of hydroxychloroquine on Th1/Th2 balance in women with repeated implantation failure. Biomed Pharmacother 107 : 1277-1285, 2018
23)Kwak-Kim J, et al : COVID-19 and immunomodulation treatment for women with reproductive failures. J Reprod Immunol 141 : 103168, 2020